Free Trial
TSE:CRDL

Cardiol Therapeutics (CRDL) Stock Price, News & Analysis

Cardiol Therapeutics logo
C$1.51 -0.05 (-3.21%)
As of 08/28/2025 04:00 PM Eastern

About Cardiol Therapeutics Stock (TSE:CRDL)

Key Stats

Today's Range
C$1.47
C$1.57
50-Day Range
C$1.40
C$2.10
52-Week Range
C$1.09
C$3.57
Volume
254,180 shs
Average Volume
98,582 shs
Market Capitalization
C$125.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CRDL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRDL Stock News Headlines

Cardiol Therapeutics Inc. (CRDL.TO) - Yahoo Finance
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.tc pixel
Stocks in play: ardiol Therapeutics Inc.
Cardiol Therapeutics added to PRISM Emerging Biotech Index
See More Headlines

CRDL Stock Analysis - Frequently Asked Questions

Cardiol Therapeutics' stock was trading at C$1.85 on January 1st, 2025. Since then, CRDL stock has decreased by 18.4% and is now trading at C$1.51.

Shares of CRDL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardiol Therapeutics investors own include Cardiol Therapeutics (CRTPF), Rolls-Royce Holdings plc (RR.L), Very Good Food (VRYYF), Gilead Sciences (GILD), Impel Pharmaceuticals (IMPL), Luminar Technologies (LAZR) and Meta Platforms (META).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
TSE:CRDL
CIK
N/A
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.51)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$42.93 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-195.07%
Return on Assets
-54.15%

Debt

Debt-to-Equity Ratio
1.59
Current Ratio
2.49
Quick Ratio
6.84

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$1.54 per share
Price / Cash Flow
0.98
Book Value
C$0.15 per share
Price / Book
10.11

Miscellaneous

Outstanding Shares
82,978,738
Free Float
N/A
Market Cap
C$125.30 million
Optionable
Not Optionable
Beta
0.70
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (TSE:CRDL) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners